This study is testing two different behavioral therapies for adolescents and young adults (ages 14-21) who have alcohol or cannabis use disorder. The therapies are called InTEGRA and MET/CBT. InTEGRA combines elements of 12-Step Facilitation with Motivational Enhancement Therapy/Cognitive Behavioral Therapy, while MET/CBT is Motivational Enhancement Therapy/Cognitive Behavioral Therapy alone. Researchers want to see if InTEGRA is effective in helping young people reduce their substance use. Success in this study means participants have more days without using substances and fewer problems related to substance use. The study is currently enrolling 294 participants in the Boston, MA, and Farmington, CT, areas.

Study design

This is a randomized controlled trial comparing two treatments, InTEGRA and MET/CBT, involving 294 participants. Participants are randomly assigned to one of the two treatment groups.

What's involved

You would undergo a phone screening, followed by a more detailed screening. If eligible, you would participate in a treatment program lasting about 3 months.

Compensation

Not stated in the trial record.

Follow-up

After treatment ends, you would have follow-up appointments every 3 months for one year to check on your progress.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.